Pattern of intravesical recurrence after surgical treatment for urothelial cancer of the upper urinary tract: A single institutional retrospective long-term follow-up study

International Journal of Urology

Volumn 17, Issue 7, 2010, Pages 623-628

  Takaoka, Ei Ichiro ^a   Hinotsu, Shiro ^a   Joraku, Akira ^a   Oikawa, Takehiro ^a   Sekido, Noritoshi ^a   Miyanaga, Naoto ^a   Kawai, Koji ^a   Shimazui, Toru ^a   Akaza, Hideyuki ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

recurrence; renal pelvis; tumor of bladder; ureter; urothelial cancer

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER RISK; CONTROLLED STUDY; DISEASE COURSE; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRIMARY TUMOR; PRIORITY JOURNAL; RETROSPECTIVE STUDY; URINARY TRACT CANCER; UROTHELIAL CANCER;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY NEOPLASMS; KIDNEY PELVIS; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; URETERAL NEOPLASMS; URINARY BLADDER NEOPLASMS;

EID: 77953837454     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2010.02539.x     Document Type: Article

References (21)

1. Mufti GR, Gove JRW, Badenoch DF et al. Transitional cell carcinoma of the renal pelvis and ureter. Br. J. Urol. 1989 63: 135 140.
2. Sakamoto N, Naito S, Kotoh S et al. Recurrence of bladder tumors following surgery for transitional cell carcinoma of the upper urinary tract. Eur. Urol. 1991 20: 136 139.
3. Lee SH, Lin JS, Tzai TS et al. Prognostic factors of primary transitional cell carcinoma of the upper urinary tract. Eur. Urol. 1996 29: 266 270.
4. Raman JD, Ng CK, Boorjian SA, Vaughan ED Jr., Sosa RE, Scherr DS. Bladder cancer after managing upper urinary tract transitional cell carcinoma: predictive factors and pathology. BJU Int. 2005 96: 1031 1035.
5. Matsui Y, Utsunomiya N, Ichioka K et al. Risk factors for subsequent development of bladder cancer after primary transitional cell carcinoma of the upper urinary tract. Urology 2005 65: 279 283.
6. Novara G, Marco VD, Dalpiaz O et al. Independent predictors of metachronous bladder transitional cell carcinoma (TCC) after nephroureterectomy for TCC of the upper urinary tract. BJU Int. 2008 101: 1368 1374.
7. Terakawa T, Miyake H, Muramaki M, Takenaka A, Hara I, Fujisawa M. Risk factors for intravesical recurrence after surgical management of transitional cell carcinoma of the upper urinary tract. Urology 2008 71: 123 127.
8. Spiessl B, Beahr OH, Hermanek P et al. UICC TMN Atlas, 3rd edn. Springer
9. Japanese Urological Association/Japanese Society of Pathology. General Rules for Clinical and Pathological Study on Renal Pelvis and Ureteral Cancer, 1st edn. Kanehara Shuppan
10. Hinotsu S, Akaza H, Ohashi Y, Kotake T. Intravesical chemotherapy for maximum prophylaxis of new early phase superficial bladder carcinoma treated by transurethral resection. A combined analysis of trials by the Japanese Urological Cancer Research Group using smoothed hazard function. Cancer 1999 86: 1818 1826.
11. Gray RJ. Some diagnostic methods for Cox regression models through hazard smoothing. Biometrics 1990 46: 93 102.
12. Bariol SV, Stewart GD, McNeill A, Tolley DA. Oncological control following laparoscopic nephroureterectomy: 7-year outcome. J. Urol. 2004 172: 1805 1808.
13. Kume H, Teramoto S, Tomita K et al. Bladder recurrence of upper urinary tract cancer after laparoscopic surgery. J. Surg. Oncol. 2006 93: 318 322.
14. Miyake H, Hara I, Kamidono S, Eto H. Multifocal transitional cell carcinoma of the bladder and upper urinary tract: molecular screening of clonal origin by characterization CD44 alternative splicing patterns. J. Urol. 2004 172: 1127 1129.
15. Hafner C, Knuechel R, Stoehr R, Hartmann A. Clonality of multifocal urothelial carcinoma: 10years of molecular genetic studies. Int. J. Cancer 2002 101: 1 6.
16. Duggan BJ, Gray SB, McKnight JJ, Watson CJ, Johnston SR, Williamson KE. Oligoclonality in bladder cancer: the implication for molecular therapies. J. Urol. 2004 171: 419 425.
17. Habuchi T, Takahashi R, Yamada H, Kakehi Y, Sugiyama T, Yoshida O. Metachronous multifocal development of urothelial cancers by intraluminal seeding. Lancet 1993 342: 1087 1088.
18. Takahashi T, Kakehi Y, Mitsumori K et al. Distinct microsatellite alterations in upper urinary tract tumors and subsequent bladder tumors. J. Urol. 2001 165: 672 677.
19. Kawanishi H, Takahashi T, Ito M et al. High throughput comparative genomic hybridization array analysis of multifocal urothelial cancers. Cancer Sci. 2006 97: 746 752.
20. Ozono S, Hinotsu S, Tabata S et al. Treated natural history of superficial bladder cancer. Jpn J. Clin. Oncol. 2001 31: 536 540.
21. Akaza H, Kurth KH, Williams R et al. Intravesical chemotherapy and immunotherapy for superficial tumors: basic mechanism of action and future direction. Urol. Oncol. 1998 4: 121 129.